(0) / view cart / checkout  
  Company Profiles
  Country Analyses
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
Aerospace, Defense
Business Services
Company Reports
Consumer Goods
Energy, Environment
Food & Beverages
Medical Devices
Sales & Marketing
Travel, Entertainment
Home >  2019 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers

2019 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts for 400 Assays, 20 Market Segments and 14 Test Locations--Emerging Opportunities and Business Expansion Strategies for Suppliers

To prepare diagnostics industry executives for radically different operating climates and reduce surprises, Venture Planning Group has published a series of 10 global market research surveys, “2019 World In Vitro Diagnostics Industry: Market Shares and Country Forecasts.  The series is designed to provide industry decision-makers with strategically significant competitor information, analyses and insight crucial to the development and implementation of effective business, marketing and R&D programs.  The report examines future trends in the U.S., Europe and Asia; reviews over 400 current and emerging assays; analyzes potential applications of innovative technologies; provides supplier shares and sales forecasts by assay, method, market segment, and country; profiles leading players and potential market entrants; and suggests alternative market expansion strategies for instrument and reagent suppliers.  The series is based on the following studies: 

     -  Future Scenarios of the In Vitro Diagnostics Market:
        Technological Breakthroughs, Economic Austerity, Business-as-Usual
     -  Opportunities in the Global Clinical Chemistry and Immunodiagnostics: 
        Spot Fast-Growing Market Segments
        Therapeutic Drug Monitoring (TDM), Endocrine Function, Tumor Markers, Special Chemistry, 
        Immunoproteins, Drugs of Abuse

     -  Analysis of the Global Molecular Diagnostics Market
        Integrating New Technology Planning with Business and Corporate Strategies--
        Emerging Tests, Market Forecasts, Competitive Intelligence  

     -  Automated Microbiology Market
        Molecular Diagnostics, Microbial Identification, Antibiotic Susceptibility, Blood Culture,
        Urine Screening, Immunodiagnostics 

     -  Infectious Disease Testing: A Rapidly Growing and Challenging Market
        Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence

     -  Market Segmentation Analysis of the Global Cancer Diagnostics Industry:
        Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical
        Stains--Hospitals, Commercial Labs, POC Locations

     -  Analysis of the Global Hematology and Flow Cytometry Markets:
        France, Germany, Italy, Japan, Spain, UK, USA Sales Forecasts, Supplier Shares,
       Competitive Strategies 

     -  Molecular Blood Typing, Grouping and Infectious Disease NAT Market:
        France, Germany, Italy, Japan, Spain, UK, US--Emerging Technologies, Sales Forecasts, 
       Supplier Shares, Competitive Strategies

     -  New Frontiers in Coagulation Testing:
        Global Challenges, Emerging Technologies, Competitive Landscape

     -  Analysis of the Global Point-of-Care Diagnostic Testing Market
        Country Segment Forecasts, Market Shares, Emerging Technologies, Competitive Strategies,
        Growth Opportunities

Report Highlights

Worldwide Market Overview

- Facilities performing diagnostic tests by country.

- Test volume and sales projections by country.

Market Segmentation Analysis

- Comprehensive review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.

- Test volume and sales forecasts for over 400 diagnostic procedures.

-  Market segments analyzed in the report include: 

  • Clinical Chemistry 
  • Immunodiagnostics
           ° TDM
           ° Endocrine Function
           ° Special Chemistry
           ° Immunoproteins
           ° Drugs of Abuse 
  • Molecular Diagnostics
           ° Infectious Diseases
           ° Cancer
           ° Genetic Testing
           ° Forensic Testing
           ° Paternity Testing/HLA Typing 
  • Microbiology
           ° Microbial Identification
           ° Antibiotic Susceptibility
           ° Urine Screening
           ° Blood Culture 
  • Cancer Diagnostic 
  • Hematology 
  • Flow Cytometry 
  • Blood Typing, Grouping, and Screening 
  • Coagulation Testing 

     - Centralized Testing Locations
       ° Hospitals
       ° Commercial/Private Laboratories
       ° Public Health Laboratories
       ° Blood Banks 

     - POC/Decentralized Testing Locations 

       ° Home/Personal Testing
       ° Physician Offices/Group Practices
       ° Emergency Rooms
       ° Operating/Recovery Suites
       ° ICUs/CCUs
       ° Cancer Clinics
       ° Ambulatory Care Centers
       ° Surgery Centers
       ° Nursing Homes
       ° Birth Centers

Emerging Tests and Instrumentation

- Analysis of current and emerging tests.

- Review of latest instrumentation technologies, and feature
comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging diagnostic technologies,
and their potential  market applications.

- Worldwide listings of companies developing
or marketing new technologies and products by test.

Strategic Recommendations

- New product development opportunities
with significant market appeal.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major diagnostic product
manufactures and emerging market entrants, including
their sales, product portfolios, marketing tactics,
collaborative arrangements and new products in R&D. 

The companies analyzed in the report include:

   - Abbott
   - ADI/America Diagnostica
   - AdnaGen/Alere
   - Affymetrix
   - Agilent Technologies
   - Alere/Biosite/Inverness
   - Applied Gene Technologies
   - Arca Biopharma
   - Axis-Shield
   - Bayer Healthcare
   - Beckman Coulter/Danaher
   - Becton Dickinson
   - Bio/Data
   - Biokit
   - Biomedical Diagnostics
   - Biomerieux
   - Bio-Rad
   - Biotest
   - Cellavision
   - CellMark Forensics/LabCorp
   - Cepheid
   - Chrono-Log
   - Corgenix Medical
   - Correlogic Systems/Vermillion
   - Decode Genetics
   - Diadexus
   - Diagast
   - Diagnocure
   - Diagnostica Stago
   - Diamedix
   - Diasorin
   - Eiken Chemical
   - EKF Diagnostics
   - Elitech Group
   - Enzo Biochem
   - Enterix
   - Epigenomics
   - Exact Sciences
   - Fujirebio
   - Gen-Probe/Hologic
   - Grifols
   - Guided Therapeutics
   - Helena Laboratories
   - Horiba
   - Hyphen BioMed
   - ID Biomedical/GSK
   - Illumina
   - Immucor
   - Instrumentation Laboratory
   - International Technidyne/Nexus DX
   - Iris Diagnostics/Danaher
   - Kreatech/Leica
   - Kyowa Medex
   - Li-Cor Biosciences
   - Lonza
   - Mackay Life Sciences
   - Matritech/Alere
   - Monogram Biosciences/LabCorp
   - Myriad Genetics
   - Nihon Kohden
   - OncoLab
   - Ortho-Clinical Diagnostics
   - Panacea Pharmaceuticals
   - Perkin Elmer/Caliper
   - Polartechnics
   - Polymedco
   - PreMD
   - Proteome Sciences
   - Qiagen
   - Quest Diagnostics
   - Quidel
   - Radiant Pharmaceuticals
   - Roche
   - Scienion
   - SDIX
   - Sequenom
   - SeraCare
   - Shimadzu
   - Siemens
   - Sienco
   - Sierra Molecular
   - Sysmex
   - Takara Bio
   - Targeted Diagnostics & Therapeutics
   - Tecan Group
   - Thermo Fisher
   - Tosoh
   - Trinity Biotech
   - Veridex
   - Wako
   - Wallac/PE
   - Zycare/Alere
   - Zyla


The report is based on a combination of primary and secondary information sources,
including questionnaire responses, as well as interviews with laboratory directors
and executives of leading diagnostic companies and start-up firms developing
innovative technologies and products in the U.S., Europe and Asia.  

In addition to primary sources of information, a comprehensive review of
Venture Planning Group’s proprietary database, and the most recent technical,
business, manufacturer, and financial publications was conducted.

Contains approximately 9,700 pages and 3,200 tables

To order sections of this report, contact Client Services

Local PDF: $175000.00
Other Formats: Global PDF, DataPack
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X